Acarix is a pioneering Swedish medical device company, with an expanding presence in the U.S., transforming cardiac diagnostics with AI-powered acoustic technology. Our flagship solution, the CADScor® System, can rapidly and non-invasively risk stratify Coronary Artery Disease, helping physicians confidently assess chest pain patients while reducing unnecessary, costly, and invasive procedures.
With CE-mark approval and FDA De Novo clearance, the CADScor®System provides a patient-specific CAD-score with 96% confidence, streamlining decision-making in both primary and specialized care. Backed by innovation and clinical validation, Acarix is committed to optimizing healthcare efficiency and improving patient care. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX) and cross-traded on the OTCQB market in the U.S. (ticker: ACIXF).
Company Details
- Employees
- 19
- Founded
- -
- Address
- Jungmansgatan 12, Malmö,skane County 211 11,sweden
- Phone
- 45 49 11 14 81
- dk****@****rix.com
- Industry
- Medical Device
- Website
- acarix.com
- HQ
- Malmö, Skane County
Acarix Questions
Acarix's helpline number is 45 49 11 14 81
Acarix's website is acarix.com
Acarix's LinkedIn profile is https://www.linkedin.com/company/acarix
Acarix has
19 employees.
View email and phone details for 19
employees at Acarix.
Acarix's industry is
Medical Device
Acarix's top competitors are
Heartbeam Inc. (Nasdaq: Beat),
Neoventa Medical,
Heartflow,
Conextions Medical,
Coala Solutions,
Epitel,
Fluidx Medical Technology, Inc.,
Brm Extremities,
Cardiacare,
Senzime.
Acarix's support email address is dkps@acarix.com
Acarix's categories are Medical Device
Acarix's founding year is 2009
